Inotek Pharmaceuticals Corporation
Latest round
- Series D
Last raised
- Jun 2010
Total raised
- $92M
Investors
- 10
About Inotek Pharmaceuticals Corporation
Founded in 1999 and based in Massachusetts, US, Inotek Pharmaceuticals Corporation is a clinical-stage, publicly traded (ITEK) biopharmaceutical company focused on the discovery and development of therapies to treat glaucoma and other diseases of the eye. In January 2018, Inotek Pharmaceuticals Corporation, a portfolio company of Care Capital, Devon Park Bioventures, MedImmune Ventures, Pitango Venture Capital, and RHO Capital Partners, merged with Rocket Pharmaceuticals. The combined company retained the Rocket Pharmaceuticals, Inc. name.
Who invested in Inotek Pharmaceuticals Corporation
10 investors across 5 rounds
See all investors in Inotek Pharmaceuticals Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inotek Pharmaceuticals Corporation
Who invested in Inotek Pharmaceuticals Corporation?
Inotek Pharmaceuticals Corporation has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inotek Pharmaceuticals Corporation raised?
Inotek Pharmaceuticals Corporation has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Inotek Pharmaceuticals Corporation last raise money?
Inotek Pharmaceuticals Corporation's most recent round on record is a Series D, in Jun 2010.
What does Inotek Pharmaceuticals Corporation do?
Founded in 1999 and based in Massachusetts, US, Inotek Pharmaceuticals Corporation is a clinical-stage, publicly traded (ITEK) biopharmaceutical company focused on the discovery and development of therapies to treat glaucoma and other diseases of the eye.
Where is Inotek Pharmaceuticals Corporation headquartered?
Inotek Pharmaceuticals Corporation is headquartered in Lexington, US.
Which VCs invest in companies like Inotek Pharmaceuticals Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Inotek Pharmaceuticals Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Inotek Pharmaceuticals Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.